Cadence Navigates Challenges Associated with COVID-19

March 23, 2020

COVID 19 Press Releaseupdated

Cadence, Inc. has maintained stable production output as the company navigates through the challenges associated with COVID-19. Production at all of Cadence’s five facilities remains at full capacity with no significant supply disruptions.

All Cadence employees remain safe with no known infection or exposure. The company has implemented a response team that meets daily to address the on-going situation. Extensive social distancing practices are also in place company-wide, as well as employee travel and visitor restrictions.

“Employee safety is our top priority while we continue to serve our customers and the patients who depend on the critical healthcare products that we provide. I am truly humbled by the effort, thoughtfulness, creativity, and empathy Cadence team members are exhibiting,” stated Alan Connor, CEO. “We stand ready to support our customers and continue to deliver critical medical products through this unprecedented time.”